0001193125-21-357891.txt : 20211215 0001193125-21-357891.hdr.sgml : 20211215 20211215160140 ACCESSION NUMBER: 0001193125-21-357891 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20211210 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant FILED AS OF DATE: 20211215 DATE AS OF CHANGE: 20211215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cano Health, Inc. CENTRAL INDEX KEY: 0001800682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39289 FILM NUMBER: 211494215 BUSINESS ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 BUSINESS PHONE: 2034227700 MAIL ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 FORMER COMPANY: FORMER CONFORMED NAME: Jaws Acquisition Corp. DATE OF NAME CHANGE: 20200121 8-K 1 d195061d8k.htm FORM 8-K Form 8-K
false 0001800682 0001800682 2021-12-10 2021-12-10 0001800682 us-gaap:CommonClassAMember 2021-12-10 2021-12-10 0001800682 us-gaap:WarrantMember 2021-12-10 2021-12-10

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 10, 2021

 

 

CANO HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39289   98-1524224

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

9725 NW 117th Avenue, Suite 200

Miami, Florida 33178

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (855) 226-6633

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Class A Common Stock, par value $0.0001 per share   CANO   The New York Stock Exchange
Warrants to purchase one share of Class A Common Stock at an exercise price of $11.50   CANO WS   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 


Item 1.01

Entry into a Material Definitive Agreement.

Amendment to Credit Agreement

On December 10, 2021, Cano Health, LLC, a Florida limited liability company and a subsidiary of Cano Health, Inc. (the “Borrower”), Primary Care (ITC) Intermediate Holdings, LLC, a Delaware limited liability company, Credit Suisse AG, Cayman Islands Branch, and the other lenders party thereto, entered into the Fifth Amendment and Incremental Facility Amendment (“Fifth Amendment”) to the Credit Agreement, dated as of November 23, 2020, pursuant to which the Borrower, among other things, increased the commitments under the revolving credit facility by an additional $60.0 million for an aggregate amount of commitments of $120.0 million.

The foregoing description of the Fifth Amendment does not purport to be complete and is qualified in its entirety by the full text of the Fifth Amendment, which will be filed as an exhibit to Cano Health, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2021.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 of this Current Report is incorporated by reference into this Item 2.03.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CANO HEALTH, INC.
Date: December 15, 2021     By:  

/s/ Dr. Marlow Hernandez

    Name:   Dr. Marlow Hernandez
    Title:   Chief Executive Officer and President
EX-101.SCH 2 cano-20211210.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 3 cano-20211210_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 cano-20211210_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Class A [Member] Common Class A [Member] Warrant [Member] Warrant [Member] EX-101.PRE 5 cano-20211210_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 d195061d8k_htm.xml IDEA: XBRL DOCUMENT 0001800682 2021-12-10 2021-12-10 0001800682 us-gaap:CommonClassAMember 2021-12-10 2021-12-10 0001800682 us-gaap:WarrantMember 2021-12-10 2021-12-10 false 0001800682 8-K 2021-12-10 CANO HEALTH, INC. DE 001-39289 98-1524224 9725 NW 117th Avenue Suite 200 Miami FL 33178 (855) 226-6633 false false false false Class A Common Stock, par value $0.0001 per share CANO NYSE Warrants to purchase one share of Class A Common Stock at an exercise price of $11.50 CANO WS NYSE true false XML 7 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Dec. 10, 2021
Document And Entity Information [Line Items]  
Amendment Flag false
Entity Central Index Key 0001800682
Document Type 8-K
Document Period End Date Dec. 10, 2021
Entity Registrant Name CANO HEALTH, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-39289
Entity Tax Identification Number 98-1524224
Entity Address, Address Line One 9725 NW 117th Avenue
Entity Address, Address Line Two Suite 200
Entity Address, City or Town Miami
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33178
City Area Code (855)
Local Phone Number 226-6633
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Common Class A [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Class A Common Stock, par value $0.0001 per share
Trading Symbol CANO
Security Exchange Name NYSE
Warrant [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Warrants to purchase one share of Class A Common Stock at an exercise price of $11.50
Trading Symbol CANO WS
Security Exchange Name NYSE
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 3 96 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d195061d8k.htm cano-20211210.xsd cano-20211210_def.xml cano-20211210_lab.xml cano-20211210_pre.xml http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d195061d8k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "cano-20211210_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "d195061d8k.htm" ] }, "labelLink": { "local": [ "cano-20211210_lab.xml" ] }, "presentationLink": { "local": [ "cano-20211210_pre.xml" ] }, "schema": { "local": [ "cano-20211210.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 31, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 2, "nsprefix": "cano", "nsuri": "http://www.canohealth.com/20211210", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d195061d8k.htm", "contextRef": "duration_2021-12-10_to_2021-12-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d195061d8k.htm", "contextRef": "duration_2021-12-10_to_2021-12-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "cano_DocumentAndEntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "localname": "DocumentAndEntityInformationLineItems", "nsuri": "http://www.canohealth.com/20211210", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "cano_DocumentAndEntityInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "localname": "DocumentAndEntityInformationTable", "nsuri": "http://www.canohealth.com/20211210", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.canohealth.com//20211210/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 14 0001193125-21-357891-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-357891-xbrl.zip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end